Artiva Biotherapeutics, Inc.
ARTV
$10.79
-$0.09-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 302.61% | -19.65% | -12.17% | -13.62% | -14.22% |
| Total Receivables | 140.17% | -21.77% | -12.74% | -14.66% | 340.17% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.11% | -65.10% | -31.46% | 0.11% | 48.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 296.98% | -21.24% | -13.02% | -13.11% | -12.32% |
|
|
|||||
| Total Current Assets | 296.98% | -21.24% | -13.02% | -13.11% | -12.32% |
| Net Property, Plant & Equipment | -7.42% | -6.10% | -5.98% | -6.89% | -4.61% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 38.19% | 0.00% | 4.55% | 76.15% | 5.27% |
| Total Assets | 247.91% | -19.08% | -12.04% | -12.12% | -11.44% |
|
|
|||||
| Total Accounts Payable | -39.37% | 543.94% | -58.14% | -30.21% | -40.32% |
| Total Accrued Expenses | 78.02% | -42.09% | 36.64% | 20.35% | -8.42% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.70% | -0.78% | -3.56% | -12.90% | -2.10% |
| Total Finance Division Other Current Liabilities | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Other Current Liabilities | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Current Liabilities | 34.02% | -16.86% | 17.70% | 3.26% | -11.77% |
|
|
|||||
| Total Current Liabilities | 34.02% | -16.86% | 17.70% | 3.26% | -11.77% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.38% | -8.31% | -7.47% | -11.09% | -6.75% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 16.69% | -13.65% | 6.78% | -3.50% | -9.48% |
|
|
|||||
| Common Stock & APIC | 64.41% | 0.34% | 0.34% | 0.37% | 0.35% |
| Retained Earnings | -7.06% | -7.11% | -6.71% | -7.47% | -7.96% |
| Treasury Stock & Other | -16.67% | -117.48% | 18.39% | 4,250.00% | -- |
| Total Common Equity | 295.58% | -20.12% | -14.90% | -13.30% | -11.70% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 295.58% | -20.12% | -14.90% | -13.30% | -11.70% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 295.58% | -20.12% | -14.90% | -13.30% | -11.70% |
|
|
|||||